Skip to main content

#151631

C-Raf KI D486A Cell Line

Cat. #151631

C-Raf KI D486A Cell Line

Cat. #: 151631

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Mouse

Tissue: Embryo

Disease: Cancer

Model: Knock-In

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Catrin Pritchard

Institute: University of Leicester

Tool Details
Target Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: C-Raf KI D486A Cell Line
  • Research fields: Cancer;Cell signaling and signal transduction;Drug development
  • Parental cell: See the Raf-1 D486A oncogenic mutant knockin mouse that these cells are produced from.
  • Organism: Mouse
  • Tissue: Embryo
  • Disease: Cancer
  • Model: Knock-In
  • Description: The C-Raf KI D486A Cell Line is derived from the knock-in mouse model carrying oncogenic Raf-1 D486A; it is useful for in vivo study of oncogenic Raf-1 mutants and Ras signalling. See the Raf-1 D486A oncogenic mutant knockin mouse that these cells are produced from.
  • Production details: Embryos were dissected and cut, washed several times with cold PBS and then incubated at 4Â?‚°C for 2 hours in 0.25% trypsin. Cells were incubated as per the growth conditions. Primary cells were immortalised and resulting cells grown out by continuous culture.

Target Details

  • Target: Raf1 D486A oncogenic mutant

Handling

  • Format: Frozen
  • Growth medium: DMEM, 10% FCS, 100U/mol penicillin/streptomycin
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: Raf-1 D486A oncogenic mutant knockin mouse

References

  • Noble et al. 2008. Mol Cell. 31(6):862-72. PMID: 18922468.
  • CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.